134 related articles for article (PubMed ID: 37460115)
1. Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease-related liver cancer by AKT.
Li S; Hao L; Deng J; Zhang J; Hu X
Chem Biol Drug Des; 2023 Oct; 102(4):828-842. PubMed ID: 37460115
[TBL] [Abstract][Full Text] [Related]
2. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
[TBL] [Abstract][Full Text] [Related]
3. [Progress in research of processing of fructus Evodiae-Rhizoma Coptidis and research thoughts and methods of its processing mechanism].
Jia X; Jiang J; Chen B; Chen Y; Hao K; Cai B; Wu H; Yang G
Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1314-7. PubMed ID: 19673400
[TBL] [Abstract][Full Text] [Related]
4. [Proportion of Coptidis rhizoma and Evodiae fructus in the compound preparation: its effect in inducing apoptosis of SGC-7901 cells].
Peng QX; Yang DJ; Shi J; Cai HB; Mo ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):226-9. PubMed ID: 21354898
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
6. [Study on the solubility changes of Rhizoma Coptidis' main chemical constituents influenced by the proportion of Rhizoma Coptidis and Fructus Evodiae].
Peng MX; Wu YJ; Cheng YY
Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):629-32. PubMed ID: 15139107
[TBL] [Abstract][Full Text] [Related]
7. Influences of Fructus evodiae pretreatment on the pharmacokinetics of Rhizoma coptidis alkaloids.
Ma BL; Yao MK; Han XH; Ma YM; Wu JS; Wang CH
J Ethnopharmacol; 2011 Oct; 137(3):1395-401. PubMed ID: 21855623
[TBL] [Abstract][Full Text] [Related]
8. [Advance in modern studies on compatibility of Coptidis Rhizoma and Evodiae Fructus].
Qiu C; Cui YL; Qi XJ; Jiang HL; Wang QS
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):582-7. PubMed ID: 26137673
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of Euodiae Fructus stir-fried with water decoction of Coptidis Rhizoma in treatment of chronic colitis based on UPLC-Q-TOF-MS, network pharmacology and experimental verification].
Zhao WY; Xiang Q; Wang C; Wu XY; Zhu YH; Yang DY; Chen YX; Xiao XL; Gong QF; Yu H
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5316-5326. PubMed ID: 36472039
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme.
Wu G; Hao Q; Liu B; Zhou J; Fan C; Liu R
Medicine (Baltimore); 2022 Sep; 101(39):e30853. PubMed ID: 36181021
[TBL] [Abstract][Full Text] [Related]
11. [Study on content variation of chemical constituents during combination of rhizoma coptidis alkaloids with fructus evodiae flavonoids by high performance liquid chromatography].
Pan L; Lü X; Xu H; Wu P
Se Pu; 2006 Mar; 24(2):168-70. PubMed ID: 16830467
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
Chi Y; Gong Z; Xin H; Wang Z; Liu Z
J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
[TBL] [Abstract][Full Text] [Related]
13. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
[TBL] [Abstract][Full Text] [Related]
14. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Rhizoma Coptidis in epilepsy with network pharmacology.
Huang D; Lv Y; Lu C; Zhang B; Fu Z; Huang Y
Allergol Immunopathol (Madr); 2022; 50(3):138-150. PubMed ID: 35527668
[TBL] [Abstract][Full Text] [Related]
16. Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking.
Li H; Luo D; Wei R; Sun M; Zhang X; Deng H; Bian W; Wei H; Huang Y
Biomed Res Int; 2022; 2022():7978258. PubMed ID: 36452059
[TBL] [Abstract][Full Text] [Related]
17. Prepared Radix Polygoni Multiflori and emodin alleviate lipid droplet accumulation in nonalcoholic fatty liver disease through MAPK signaling pathway inhibition.
Huang C; Zhang Y; Xu Y; Wei S; Yang T; Wang S; Li C; Lin H; Li X; Zhao S; Zhu L; Pan W
Aging (Albany NY); 2024 Jan; 16(3):2362-2384. PubMed ID: 38284886
[TBL] [Abstract][Full Text] [Related]
18. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
20. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
